Literature DB >> 23078046

Quantitative prediction of antitarget interaction profiles for chemical compounds.

Alexey V Zakharov1, Alexey A Lagunin, Dmitry A Filimonov, Vladimir V Poroikov.   

Abstract

The evaluation of possible interactions between chemical compounds and antitarget proteins is an important task of the research and development process. Here, we describe the development and validation of QSAR models for the prediction of antitarget end-points, created on the basis of multilevel and quantitative neighborhoods of atom descriptors and self-consistent regression. Data on 4000 chemical compounds interacting with 18 antitarget proteins (13 receptors, 2 enzymes, and 3 transporters) were used to model 32 sets of end-points (IC(50), K(i), and K(act)). Each set was randomly divided into training and test sets in a ratio of 80% to 20%, respectively. The test sets were used for external validation of QSAR models created on the basis of the training sets. The coverage of prediction for all test sets exceeded 95%, and for half of the test sets, it was 100%. The accuracy of prediction for 29 of the end-points, based on the external test sets, was typically in the range of R(2)(test) = 0.6-0.9; three tests sets had lower R(2)(test) values, specifically 0.55-0.6. The proposed approach showed a reasonable accuracy of prediction for 91% of the antitarget end-points and high coverage for all external test sets. On the basis of the created models, we have developed a freely available online service for in silico prediction of 32 antitarget end-points: http://www.pharmaexpert.ru/GUSAR/antitargets.html.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23078046      PMCID: PMC3534763          DOI: 10.1021/tx300247r

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  15 in total

1.  Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.

Authors:  Y Z Chen; C Y Ung
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

Review 2.  Prediction of biological activity spectra via the Internet.

Authors:  A Sadym; A Lagunin; D Filimonov; V Poroikov
Journal:  SAR QSAR Environ Res       Date:  2003 Oct-Dec       Impact factor: 3.000

3.  Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.

Authors:  Giulio Vistoli; Alessandro Pedretti; Luigi Villa; Bernard Testa
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

Review 4.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

5.  GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.

Authors:  Thomas Klabunde; Andreas Evers
Journal:  Chembiochem       Date:  2005-05       Impact factor: 3.164

Review 6.  Cell-mediated side effects of psychopharmacological treatment.

Authors:  I Maurer; H P Volz
Journal:  Arzneimittelforschung       Date:  2001-10

7.  Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.

Authors:  M L López-Rodríguez; M L Rosado; B Benhamú; M J Morcillo; E Fernández; K J Schaper
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

8.  Theoretical quantitative structure-activity relationship analysis on three dimensional models of ligand-m1 muscarinic receptor complexes.

Authors:  F Fanelli; M C Menziani; A Carotti; P G De Benedetti
Journal:  Bioorg Med Chem       Date:  1994-03       Impact factor: 3.641

9.  A new approach to QSAR modelling of acute toxicity.

Authors:  A A Lagunin; A V Zakharov; D A Filimonov; V V Poroikov
Journal:  SAR QSAR Environ Res       Date:  2007 May-Jun       Impact factor: 3.000

10.  Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant.

Authors:  D Larrey; A Berson; F Habersetzer; M Tinel; A Castot; G Babany; P Lettéron; E Freneaux; J Loeper; P Dansette
Journal:  Hepatology       Date:  1989-08       Impact factor: 17.425

View more
  14 in total

1.  Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.

Authors:  Stephen J Capuzzi; Wei Sun; Eugene N Muratov; Carles Martínez-Romero; Shihua He; Wenjun Zhu; Hao Li; Gregory Tawa; Ethan G Fisher; Miao Xu; Paul Shinn; Xiangguo Qiu; Adolfo García-Sastre; Wei Zheng; Alexander Tropsha
Journal:  J Med Chem       Date:  2018-04-17       Impact factor: 7.446

2.  QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors.

Authors:  Olga A Tarasova; Aleksandra F Urusova; Dmitry A Filimonov; Marc C Nicklaus; Alexey V Zakharov; Vladimir V Poroikov
Journal:  J Chem Inf Model       Date:  2015-06-29       Impact factor: 4.956

3.  Alarms about structural alerts.

Authors:  Vinicius Alves; Eugene Muratov; Stephen Capuzzi; Regina Politi; Yen Low; Rodolpho Braga; Alexey V Zakharov; Alexander Sedykh; Elena Mokshyna; Sherif Farag; Carolina Andrade; Victor Kuz'min; Denis Fourches; Alexander Tropsha
Journal:  Green Chem       Date:  2016-06-28       Impact factor: 10.182

4.  In silico estrogen receptor alpha antagonist studies and toxicity prediction of Melia azedarach leaves bioactive ethyl acetate fraction.

Authors:  Martha Ervina; Mohammad Rizki Fadhil Pratama; Hadi Poerwono; Juni Ekowati; Retno Widyowati; Katsuyoshi Matsunami
Journal:  J Adv Pharm Technol Res       Date:  2021-07-16

5.  A new approach to radial basis function approximation and its application to QSAR.

Authors:  Alexey V Zakharov; Megan L Peach; Markus Sitzmann; Marc C Nicklaus
Journal:  J Chem Inf Model       Date:  2014-02-28       Impact factor: 4.956

6.  QSAR models of human data can enrich or replace LLNA testing for human skin sensitization.

Authors:  Vinicius M Alves; Stephen J Capuzzi; Eugene Muratov; Rodolpho C Braga; Thomas Thornton; Denis Fourches; Judy Strickland; Nicole Kleinstreuer; Carolina H Andrade; Alexander Tropsha
Journal:  Green Chem       Date:  2016-10-06       Impact factor: 10.182

7.  QSAR modeling of imbalanced high-throughput screening data in PubChem.

Authors:  Alexey V Zakharov; Megan L Peach; Markus Sitzmann; Marc C Nicklaus
Journal:  J Chem Inf Model       Date:  2014-02-28       Impact factor: 4.956

8.  Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidiabetic agents.

Authors:  Elena V Fedorova; Anna V Buryakina; Alexey V Zakharov; Dmitry A Filimonov; Alexey A Lagunin; Vladimir V Poroikov
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

9.  Drug-likeness of Phytic Acid and Its Analogues.

Authors:  Amitha Joy; S Balaji
Journal:  Open Microbiol J       Date:  2015-11-03

10.  Comparison of Quantitative and Qualitative (Q)SAR Models Created for the Prediction of Ki and IC50 Values of Antitarget Inhibitors.

Authors:  Alexey A Lagunin; Maria A Romanova; Anton D Zadorozhny; Natalia S Kurilenko; Boris V Shilov; Pavel V Pogodin; Sergey M Ivanov; Dmitry A Filimonov; Vladimir V Poroikov
Journal:  Front Pharmacol       Date:  2018-10-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.